Markets.com Logo

NBIO

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    0.0006$
  • Previous Close
    0.0006$
  • 52 Week Change
    0.10$
  • Day Range
    0.00$
  • 52 Week High/Low
    0.0001$ - 0.0952$
  • Dividend Per Share
    --
  • Market cap
    103 K$
  • EPS
    -0.0015
  • Beta
    -2.709
  • Volume
    --

About

NeuroBo Pharmaceuticals, Inc. (NBIO.US) is a clinical-stage biotechnology company focused on developing and commercializing novel, disease-modifying therapies for neurodegenerative and cardiometabolic diseases. Their pipeline includes treatments for diabetic neuropathic pain (DPN), Alzheimer's disease, and obesity. The company's research and development efforts are centered on addressing unmet medical needs in these areas.

Fed's New Era: Warsh Signals Caution Amid Inflation and Market Jitters

Emma Rose|--

Storage Chip Sector Rebound: Is AI Sustaining the Cycle?

Sophia Claire|--

New Fed Chair Kevin Warsh: Reshaping Communication and Steering Market Expectations

Emma Rose|--

Goldman Sachs Revises 2027 Brent Crude Forecast to $80/bbl Amid Shifting Supply and Demand Dynamics

Sophia Claire|--

US Stock Market Volatility Surges as Trading Logic Breaks Down

Emma Rose|--

2026 World Cup: A Watershed Moment for Predictive Markets and a Boost for DraftKings

Emma Rose|--

Japanese Tungsten Hexafluoride Production Halt Disrupts Global Semiconductor Supply Chain

Sophia Claire|--

Factors

Clinical Trial Results: Positive trial outcomes typically boost stock price, while failures can cause significant drops.

Regulatory Approvals: FDA approval of NBIO's products or therapies can lead to increased investor confidence and higher stock value.

Competition: The emergence of competing treatments or technologies could negatively affect NBIO's market share and stock price.

Market Sentiment: Overall investor mood and economic conditions can influence the demand for NBIO's stock, regardless of company-specific news.

Partnerships/Acquisitions: Collaborations or acquisitions involving NBIO can signal growth potential and attract investors.

Financial Performance: Strong revenue growth and profitability can make NBIO's stock more attractive to investors.

People Also Watch

Latest news

Qatar's Delicate Energy Diplomacy Amidst Regional Conflict: A Balancing Act

Sophia Claire|--

Lebanon: A Geopolitical Chessboard of Iranian Influence and US Diplomacy

Emma Rose|--

Global Market Snapshot: Key Events and Analysis of Financial Markets

Liam James|--

Latest Education Articles

Most Volatile Forex Pairs: What Traders Should Know

Most Volatile Forex Pairs: What Traders Should Know

Julian Parker|--
What Happens on the Day of an IPO?

What Happens on the Day of an IPO?

Julian Parker|--
10 Hot IPO Stocks to Watch in 2026: SpaceX, Anthropic, OpenAI and More

10 Hot IPO Stocks to Watch in 2026: SpaceX, Anthropic, OpenAI and More

Julian Parker|--
Recommended Topics